Medi Welcome Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
150
- Stock Symbol
-
02159
- Investments
-
1
- Share Price
-
$0.20
- (As of Friday Closing)
Medi Welcome General Information
Description
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
Contact Information
Website
www.mediwelcome.comCorporate Office
- Floor 10-12, Shangdong Park Lane
- No. 2 Dongsihuan North Road, Chaoyang District
- Beijing, 100101
- China
Corporate Office
- Floor 10-12, Shangdong Park Lane
- No. 2 Dongsihuan North Road, Chaoyang District
- Beijing, 100101
- China
Medi Welcome Stock Performance
As of 13-Nov-2026, Medi Welcome’s stock price is $0.20. Its current market cap is $66.9M with 328M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.20 | $0.21 | $0.14 - $0.29 | $66.9M | 328M | 126K | $0.02 |
Medi Welcome Financials Summary
As of 30-Jun-2026, Medi Welcome has a trailing 12-month revenue of $81.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 48,888 | 35,092 | 5,588 | (3,303) |
| Revenue | 81,728 | 65,081 | 44,814 | 46,829 |
| EBITDA | 5,106 | 1,812 | (4,738) | (10,592) |
| Net Income | 4,861 | 1,389 | (6,306) | (13,300) |
| Total Assets | 65,924 | 27,225 | 26,587 | 30,234 |
| Total Debt | 9,584 | 7,785 | 6,538 | 4,392 |
Medi Welcome Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medi Welcome Signals
Medi Welcome Investments (1)
Medi Welcome’s most recent deal was a Corporate with Leadinno Medical Valley. The deal was made on 14-Mar-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Leadinno Medical Valley | 14-Mar-2019 | Corporate | Therapeutic Devices |
Medi Welcome ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
Medi Welcome FAQs
-
When was Medi Welcome founded?
Medi Welcome was founded in 2000.
-
Where is Medi Welcome headquartered?
Medi Welcome is headquartered in Beijing, China.
-
What is the size of Medi Welcome?
Medi Welcome has 150 total employees.
-
What industry is Medi Welcome in?
Medi Welcome’s primary industry is Media and Information Services (B2B).
-
Is Medi Welcome a private or public company?
Medi Welcome is a Public company.
-
What is Medi Welcome’s stock symbol?
The ticker symbol for Medi Welcome is 02159.
-
What is the current stock price of Medi Welcome?
As of 13-Nov-2026 the stock price of Medi Welcome is $0.20.
-
What is the current market cap of Medi Welcome?
The current market capitalization of Medi Welcome is $66.9M.
-
What is Medi Welcome’s current revenue?
The trailing twelve month revenue for Medi Welcome is $81.7M.
-
What is Medi Welcome’s annual earnings per share (EPS)?
Medi Welcome’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process